YA II PN, Ltd. Exits Position in Indaptus Therapeutics, Inc. (INDP)

YA II PN, Ltd. and its affiliates, including Yorkville Advisors Global, LP and Mark Angelo, filed a Schedule 13G/A on April 6, 2026, regarding their holdings in Indaptus Therapeutics, Inc. (INDP). The filing indicates that the reporting group has fully exited its position in the company's common stock as of December 31, 2025. Specifically, the reporting persons now beneficially own 0 shares, representing 0.0% of the class. This amendment follows a previous position where the group held a stake in the issuer. The entities involved include several Yorkville-affiliated funds and management companies, all of which reported zero voting and dispositive power over any shares of Indaptus Therapeutics. The filing was signed by David Gonzalez, General Counsel, and Mark Angelo, confirming that the securities were not held for the purpose of changing or influencing the control of the issuer.